Loading company details...
Beta
Latest Form 4 (Oct 17, 2026): Matthew Rabinowitz (EXECUTIVE CHAIRMAN): Exercise/Conversion of 50,000 shares, $520.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2026 | Matthew Rabinowitz, EXECUTIVE CHAIRMAN | Exercise/Conversion | 50,000 | $520.5K |
| Oct 10, 2026 | Matthew Rabinowitz, EXECUTIVE CHAIRMAN | Gift | 6,000 | n/a |
| Oct 3, 2026 | Steven Leonard Chapman, CEO AND PRESIDENT | Sale | 1,273 | $526.1K |
| Oct 3, 2026 | Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS | Sale | 200 | $82.3K |
| Sep 26, 2026 | Jonathan Sheena | Sale | 400 | $154.0K |
| Sep 19, 2026 | Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS | Gift | 945 | n/a |
| Sep 18, 2026 | Jonathan Sheena | Sale | 6,000 | $2.10M |
| Sep 17, 2026 | Matthew Rabinowitz, EXECUTIVE CHAIRMAN | Sale | 1,537 | $504.3K |
| Sep 12, 2026 | Matthew Rabinowitz, EXECUTIVE CHAIRMAN | Sale | 800 | $260.0K |
| Sep 4, 2026 | Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,000 | $319.8K |